News - B type
Amgen Highlights Biomarker and Preclinical Data to be Presented at American Association for Cancer Research (AACR) Annual Meeting
THOUSAND OAKS, Calif., April 12 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that results from several preclinical studies investigating potential new cancer agents and a comprehensive biomarker analysis will be presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.
Device Fuses Cells For Stem Cell Research
MIT engineers have developed a new, highly efficient way to pair up cells so they can be fused together into a hybrid cell.
Recall of Vaccine Prompts Dose Deferral
ATLANTA - Federal health officials on Wednesday said doctors should temporarily stop giving children the final booster shot of the Hib vaccine because of expected shortages caused by a recall.
OPINION: My Tight Pants? My Friends' Fault
By Elmer Smith, Philadelphia Daily News Jul. 27--DOES THIS FRIEND make my butt look big? No, really. I've found solid scientific evidence that the inexorable expansion of my, uh, southern sector can be blamed on the company I keep. I wouldn't have believed it either.
Lotus Reports on Its Hepatitis B Drug Development
Lotus Pharmaceuticals has reported new developments in the formulation of its hepatitis B drug that could add an additional $6 million annually in net profits for the Beijing company.